139 related articles for article (PubMed ID: 33261317)
21. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
22. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
[TBL] [Abstract][Full Text] [Related]
23. The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10.
Bros M; Montermann E; Cholaszczyńska A; Reske-Kunz AB
Int Immunopharmacol; 2016 Jun; 35():174-184. PubMed ID: 27070502
[TBL] [Abstract][Full Text] [Related]
24. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.
Farid HA; Sayed RH; El-Shamarka ME; Abdel-Salam OME; El Sayed NS
Inflammopharmacology; 2024 Apr; 32(2):1421-1437. PubMed ID: 37541971
[TBL] [Abstract][Full Text] [Related]
25. Roflumilast ameliorates cognitive deficits in a mouse model of amyloidogenesis and tauopathy: Involvement of nitric oxide status, Aβ extrusion transporter ABCB1, and reversal by PKA inhibitor H89.
Ashour NH; El-Tanbouly DM; El Sayed NS; Khattab MM
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110366. PubMed ID: 34051306
[TBL] [Abstract][Full Text] [Related]
26. cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress.
Luo Y; Kuang S; Li H; Ran D; Yang J
Oncotarget; 2017 May; 8(22):35558-35572. PubMed ID: 28415673
[TBL] [Abstract][Full Text] [Related]
27. The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice.
Liu X; Hao PD; Yang MF; Sun JY; Mao LL; Fan CD; Zhang ZY; Li DW; Yang XY; Sun BL; Zhang HT
Psychopharmacology (Berl); 2017 Aug; 234(16):2409-2419. PubMed ID: 28477089
[TBL] [Abstract][Full Text] [Related]
28. MnO
Song C; Wu J; Wu J; Wang F
J Nanobiotechnology; 2024 May; 22(1):294. PubMed ID: 38807127
[TBL] [Abstract][Full Text] [Related]
29. Citrus flavonoid 3,5,6,7,8,3',4'-heptamethoxyflavone induces BDNF via cAMP/ERK/CREB signaling and reduces phosphodiesterase activity in C6 cells.
Sawamoto A; Okuyama S; Nakajima M; Furukawa Y
Pharmacol Rep; 2019 Aug; 71(4):653-658. PubMed ID: 31195342
[TBL] [Abstract][Full Text] [Related]
30. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
[TBL] [Abstract][Full Text] [Related]
31. Theobromine up-regulates cerebral brain-derived neurotrophic factor and facilitates motor learning in mice.
Yoneda M; Sugimoto N; Katakura M; Matsuzaki K; Tanigami H; Yachie A; Ohno-Shosaku T; Shido O
J Nutr Biochem; 2017 Jan; 39():110-116. PubMed ID: 27833051
[TBL] [Abstract][Full Text] [Related]
32. Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering.
Xu R; Fu J; Hu Y; Yang X; Tao X; Chen L; Huang K; Fu Q
Diabetes; 2022 Aug; 71(8):1660-1678. PubMed ID: 35594380
[TBL] [Abstract][Full Text] [Related]
33. Role of PKA/CREB/BDNF signaling in PM2.5-induced neurodevelopmental damage to the hippocampal neurons of rats.
Liu J; Liu B; Yuan P; Cheng L; Sun H; Gui J; Pan Y; Huang D; Chen H; Jiang L
Ecotoxicol Environ Saf; 2021 May; 214():112005. PubMed ID: 33640725
[TBL] [Abstract][Full Text] [Related]
34. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
[TBL] [Abstract][Full Text] [Related]
35. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.
Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F
Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985
[TBL] [Abstract][Full Text] [Related]
36. Curcumin confers neuroprotection against alcohol-induced hippocampal neurodegeneration via CREB-BDNF pathway in rats.
Motaghinejad M; Motevalian M; Fatima S; Hashemi H; Gholami M
Biomed Pharmacother; 2017 Mar; 87():721-740. PubMed ID: 28095363
[TBL] [Abstract][Full Text] [Related]
37. Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study.
Blokland A; Van Duinen MA; Sambeth A; Heckman PRA; Tsai M; Lahu G; Uz T; Prickaerts J
Neurobiol Aging; 2019 May; 77():37-43. PubMed ID: 30776650
[TBL] [Abstract][Full Text] [Related]
38. Aminoguanidine reverses cognitive deficits and activation of cAMP/CREB/BDNF pathway in mouse hippocampus after traumatic brain injury (TBI).
Wang W; Shen M; Sun K; Wang Y; Wang X; Jin X; Xu J; Ding L; Sun X
Brain Inj; 2018; 32(13-14):1858-1865. PubMed ID: 30346862
[TBL] [Abstract][Full Text] [Related]
39. Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice.
Guo J; Lin P; Zhao X; Zhang J; Wei X; Wang Q; Wang C
Neuroscience; 2014 Mar; 263():1-14. PubMed ID: 24434771
[TBL] [Abstract][Full Text] [Related]
40. Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
Xu X; Liao L; Hu B; Jiang H; Tan M
Med Sci Monit; 2020 May; 26():e921319. PubMed ID: 32449901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
